Journal article

Publication year: 2000

Pages: 414-423

Journal: Experimental and Clinical Endocrinology & Diabetes

Volume number: 108

Issue number: 6

ISSN: 0947-7349

eISSN: 1439-3646

DOI Link: https://doi.org/10.1055/s-2000-8400

Publisher: Thieme Publishing

Abstract: 
Although numerous clinical studies have demonstrated the beneficial effect of preventing postmenopausal bone loss in elder women by long-term estrogen administration, effects of estrogen at the cellular level still remain unclear. Efforts to determine the precise role of bone cells in estrogen-mediated pathways are often hampered by the lack of suitable cell culture models. Presuming that sex steroids have a direct, stimulating effect on bone cells in vitro, we investigated the influence of 17 beta-estradiol, testosterone and 1.25(OH)(2)D-3 on cell proliferation and differentiation using four established human osteosarcoma (HOS) cell lines of different gender of the donors (male origin: MG 63, HOS 58; female origin: SaOS 2, TE 85). These cell Lines are believed to represent different stages of osteogenic maturation. Thus, the aim of this study was to clarify if possible responses to sex steroids are related to gender or osteogenic commitment of the individual cell culture. HOS cells were cultured in six-well plates and underwent hormone treatment (1 nM and 10 nM 17 beta-estradiol, 0.1 nM and 1 nhl testosterone and 1 mu M 1,25(OH)(2)D-3) for 48 h hours. Cell proliferation was determined by measuring total cell numbers. Cell function was studied by measuring alkaline phosphatase activity and secreted osteocalcin. Ln this study, estrogen significantly increased proliferation of both one male (MG 63) and one female (SaOSZ) cell line, but decreased proliferation of the female HOS TE 85 cell line significantly. Testosterone treatment had a positive effect on proliferation of only one female cell line (SaOS 2). A significant increase of alkaline phosphatase activity in SaOS ? and HOS 58 cells and of osteocalcin levels in SaOS 2 cells was detected following estrogen treatment. Administration of 1,25(OH)(2)D-3 was followed by an increased cell proliferation in HOS 58, MG 63 and SaOS 2. Significant gender-related differences could not be demonstrated. In conclusion, response to hormonal treatment with sex steroids is not related to the gender of the osteosarcoma cell line, but rather depends on its osteoblastic commitment.

Harvard Citation style: Fohr, B., Schulz, A. and Battmann, A. (2000) Sex steroids and bone metabolism:: Comparison of in vitro effects of 17β-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation, Experimental and Clinical Endocrinology & Diabetes, 108(6), pp. 414-423. https://doi.org/10.1055/s-2000-8400

APA Citation style: Fohr, B., Schulz, A., & Battmann, A. (2000). Sex steroids and bone metabolism:: Comparison of in vitro effects of 17β-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation. Experimental and Clinical Endocrinology & Diabetes. 108(6), 414-423. https://doi.org/10.1055/s-2000-8400